Abpro Holdings (ABP)

• Market cap: $13.7M
• 1 day: 5.64%
• 5 days: -16.36%
• 1 month: -17.72%
• 3 months: -30.87%
• 6 months: -19.17%
• Year to date: -89.26%
• 1 year: -88.68%
• 5 years: -98.3%
• 10 years: -98.3%
• Sector: Healthcare
• Industry: Biotechnology

About: Abpro Holdings Inc is a biotechnology company dedicated to developing next-generation antibody therapeutics with the goal of improving the lives of patients with severe and life-threatening diseases. It is focused on novel antibody constructs for immuno-oncology and ophthalmology. By leveraging its proprietary DiversImmune and MultiMabTM antibody discovery and engineering platforms. The company is developing a pipeline of next-generation antibodies, both independently and through collaborations with pharmaceutical and research institutions.

Employees: 6